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Abstract

Case Details

Discussion

Antegrade placement of ureteral stents is common after
nephrostomy tube placement for obstruction in the septic
patient and when retrograde placement fails. Ureteral stents
have a nylon retaining suture attached to aid in placement. If
left in place accidentally, these will not degrade and will
become embedded in the renal parenchyma preventing stent
removal and potentially leading to infection and stone
formation. Ureteroscopic holmium ablation of the residual
suture at the level of the parenchyma allows for stent removal
and no urothelial defect was noted on repeat ureteroscopy 3
weeks later. Ureteroscopy with holmium lasering of retained
suture appears safe for removal of retained stents with no
symptoms related to suture left in the renal parenchyma and
no visible defect seen on follow-up renoscopy.

A 95M with ESRD due to HTN on HD for 7 months presented for
bilateral JJ stent removal. He had initially been diagnosed with acute
renal failure 6 years earlier where he was managed acutely with
bilateral PCN and Foley placement. He subsequently underwent a TURP
and internal JJ stent placement. At that time, he was diagnosed with
chronic kidney disease due to hypertension as well as bilateral UPJ
obstructions. He has undergone routine JJ stent changes dozens of
times. He acutely presented to the hospital in worsening renal failure
with creatinine 6.9 from baseline 5 and started on HD 7 months prior to
his stent removal. At that time, he had his Right stent changed but was
unable to replace the left JJ stent after removal, therefore
Interventional radiology placed a left PCN, which was internalized to an
8 fr x 26 cm JJ stent 3 days later (Figure 1). He was continued on
routine HD as an outpatient and treated for enterococcus and
pseudomonas UTI. 7 months later he presented for stent removal as he
made little urine on HD and nephrology was concerned for infection
risk. The patient had no reported issues with the stents, KUB and
fluoroscopy saw no malpositioning or encrustation prior or during the
case.
The patient was in the dorsal lithotomy position and the right stent
was removed with flexible graspers, however the left stent did not
come easily and was fixed in position. This was straightened with a wire
through the stent but still would not remove despite no retaining curl
seen. Ureteroscopy alongside the stent showed a blue string preventing
the stent to be removed (Figure 2). We used the holmium laser on
dusting settings to cut the proximal part of the string and allow the
stent to be removed (Figure 3). We then were able to perform
renoscopy and saw that the string was attached to a papilla in the lower
pole but was unable to be removed by grasping with ureteroscopic
graspers (Figure 4). At this point we again used the holmium laser to
cut right on the papilla and remove the remaining string with the
graspers (Figure 5). There was a small piece of string left in the
parenchyma that was unable to be removed. Gross appearance of the
string can be seen in Figure 6.
Due to the amount of trauma to remove the stent, a new left JJ stent
was placed with outpatient ureteroscopy performed three weeks
later. On repeat renoscopy there were no defects seen in the papilla
and the patient was left without ureteric stents. On 10-month follow up
the patient is continued on HD and has had no UTI, flank pain, or repeat
Urologic interventions.

At our institution we commonly enlist Interventional
Radiology for internalization of percutaneous nephrostomy tubes
to JJ stents. This likely represents an unreported retained suture
from the internalized stent that has ingrown into the renal
parenchyma. There was no reported difficulty in placement per
the procedural note and no skin defect. The incidence of this
occurring is unknown and no similar case reports could be found
on literature review. The string was unable to be pulled with
graspers but laser ablation of the string appeared to remove all
components in the collecting system despite likely leaving behind
a short segment in the renal parenchyma.
Foreign bodies can become a nidus for stones and infection,
however at 10-month follow up the patient has had no UTIs or
urologic complications. There was no defect seen on repeat
renoscopy and it appears no deleterious effects of whatever
retained intraparenchymal string persists, if any. Our case had
apparent good success with laser ablation, however it is unclear
if ESWL or PCNL would be alternative options if ureteroscopy
failed.
On the packaging for ureteric stents it states the suture is
monofilament but does not state its material. After discussions
with a large JJ stent producing company’s representative it was
determined to be nylon. This is a non-absorbable suture and
likely would not dissolve over time and form stones if not
removed promptly. Future production considerations to change
the suture to a dissolvable suture would likely eliminate this rare
complication.

Introduction
Ureteral obstruction is caused by malignancy, stones,
external compression, congenital defects, and iatrogenic
injuries (source). Subsequent hydronephrosis can be
decompressed by antegrade or retrograde access. Retrograde
access is via cystoscopy, while antegrade access is performed
typically by interventional radiology with a percutaneous
nephrostomy tube (PCN), percutaneous nephroureteral
catheter (PCNU), or percutaneous antegrade ureteral
catheter. These are placed over a wire with the Seldinger
technique and typically place catheters from 4.7 French to 10
French in size. These are performed under fluoroscopy to
ensure positioning. Depending on the catheter used there is a
lifespan ranging from 3-12 months prior to necessary removal
to avoid encrustation, obstruction, fracture, infection. These
stents have a permanent monofilament nylon suture at the
end to facilitate placement and subsequent removal of the
stent (Bard packaging). When not removed, these sutures can
present a difficult challenge for ureteric stent removal.

Figure 1: fluoroscopy of left antegrade
JJ stent placement
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Figure 2: suture seen along JJ stent

Figure 3: Residual suture after holmium ablation
and JJ stent removal

Figure 4: Insertion point of suture in
lower pole papilla
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Conclusions
Retained suture from an antegrade ureteric stent appears to
be a rare phenomenon preventing simple cystoscopic stent
removal. Ureteroscopy with holmium lasering of retained suture
appears safe for removal of retained stents with suture left in the
renal parenchyma with no visible defect seen on follow-up
renoscopy.

Figure 5: Holmium ablation of
residual suture at lower pole papilla

Figure 6: Gross specimen after ureteroscopic
extraction
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